Nikolaos Touroutoglou is an expert in the field of Hematology. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Nikolaos Touroutoglou is also published. He has 6 publications published. The lastest publication: "Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors.' Nikolaos Touroutoglou accepts Medicare.
|
Dr. Nicholas J. Vogelzang, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Dimitrios T. Diamandidis, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Grzegorz S. Obara, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Fadi Braiteh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Anu R. Thummala, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ann M. Wierman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Xiantuo Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Neal J. Prendergast, MD
|
|
Dr. Joseph Quagliana, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Christine Ruemmler-Fisch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rinah I. Shopnick, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yupo Ma, MD
|
|
Dr. Shahid P. Malik, MD
This Doctor is OpenDoctor Recommended.
|